A
Andreas Mayr
Researcher at Johannes Kepler University of Linz
Publications - 40
Citations - 4349
Andreas Mayr is an academic researcher from Johannes Kepler University of Linz. The author has contributed to research in topics: Computer science & Medicine. The author has an hindex of 16, co-authored 27 publications receiving 3444 citations. Previous affiliations of Andreas Mayr include Johnson & Johnson Pharmaceutical Research and Development.
Papers
More filters
Posted Content
Self-Normalizing Neural Networks
TL;DR: Self-normalizing neural networks (SNNs) are introduced to enable high-level abstract representations and it is proved that activations close to zero mean and unit variance that are propagated through many network layers will converge towards zero meanand unit variance -- even under the presence of noise and perturbations.
Journal ArticleDOI
DeepTox: Toxicity Prediction using Deep Learning
TL;DR: DeepTox had the highest performance of all computational methods winning the grand challenge, the nuclear receptor panel, the stress response panel, and six single assays (teams ``Bioinf@JKU'').
Proceedings Article
Self-Normalizing Neural Networks
TL;DR: Self-normalizing neural networks (SNNs) as discussed by the authors have been proposed to enable high-level abstract representations and achieve state-of-the-art performance on many tasks.
Journal ArticleDOI
cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate
Günter Klambauer,Karin Schwarzbauer,Andreas Mayr,Djork-Arné Clevert,Andreas Mitterecker,Ulrich Bodenhofer,Sepp Hochreiter +6 more
TL;DR: ‘Copy Number estimation by a Mixture Of PoissonS’ (cn.MOPS), a data processing pipeline for CNV detection in NGS data outperformed its five competitors in terms of precision (1–FDR) and recall for both gains and losses in all benchmark data sets.
Journal ArticleDOI
Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
Andreas Mayr,Günter Klambauer,Thomas Unterthiner,Marvin Steijaert,Jörg K. Wegner,Hugo Ceulemans,Djork-Arné Clevert,Sepp Hochreiter +7 more
TL;DR: The to date largest comparative study of nine state-of-the-art drug target prediction methods finds that deep learning outperforms all other competitors.